Related references
Note: Only part of the references are listed.Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets
Daphne de Launay et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF
Gabi Tarcic et al.
FASEB JOURNAL (2012)
Contrasting effects of A1 and A2b adenosine receptors on adipogenesis
B. Gharibi et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation
Jessica Perez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Akt signalling in health and disease
Ingeborg Hers et al.
CELLULAR SIGNALLING (2011)
High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt
S. Liu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Adenosine Receptor Subtype Expression and Activation Influence the Differentiation of Mesenchymal Stem Cells to Osteoblasts and Adipocytes
Borzo Gharibi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Spata4 Promotes Osteoblast Differentiation Through Erk-Activated Runx2 Pathway
Xiaoyan Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Manifestations and mechanisms of stem cell aging
Ling Liu et al.
JOURNAL OF CELL BIOLOGY (2011)
Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals
Jennifer Veevers-Lowe et al.
JOURNAL OF CELL SCIENCE (2011)
PDGF signalling controls age-dependent proliferation in pancreatic β-cells
Hainan Chen et al.
NATURE (2011)
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
Wei Ding et al.
BLOOD (2010)
Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer
Shioto Suzuki et al.
BMC CANCER (2010)
Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways
T. Makino et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas
Hongwu Zheng et al.
CANCER CELL (2010)
A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
Carolyn V. Ustach et al.
CANCER RESEARCH (2010)
The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation
Hai-Kun Liu et al.
GENES & DEVELOPMENT (2010)
Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPAR gamma expression and phosphorylation
Ling Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway
Venkata Ramesh Dasari et al.
PLOS ONE (2010)
Platelet-Derived Growth Factor Receptor Signaling Is Not Involved in Osteogenic Differentiation of Human Mesenchymal Stem Cells
Akhilesh Kumar et al.
TISSUE ENGINEERING PART A (2010)
Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes
Min Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Mesenchymal Stem Cells: Flip Side of the Coin
Pravin J. Mishra et al.
CANCER RESEARCH (2009)
Evodiamine inhibits adipogenesis via the EGFR-PKCα-ERK signaling pathway
Ting Wang et al.
FEBS LETTERS (2009)
Wnt signaling controls the fate of mesenchymal stem cells
Ling Ling et al.
GENE (2009)
Erk1/2 MAP kinases are required for epidermal G2/M progression
Phillip A. Dumesic et al.
JOURNAL OF CELL BIOLOGY (2009)
Akt promotes BMP2-mediated osteoblast differentiation and bone development
Aditi Mukherjee et al.
JOURNAL OF CELL SCIENCE (2009)
Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine
Neeraj Kumar Satija et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Targeting the mTOR Signaling Network for Cancer Therapy
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
Hui H. Zhang et al.
PLOS ONE (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Self-renewal and differentiation capacity of young and aged stem cells
Valerie D. Roobrouck et al.
EXPERIMENTAL CELL RESEARCH (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
UCP2 Modulates Cell Proliferation through the MAPK/ERK Pathway during Erythropoiesis and Has No Effect on Heme Biosynthesis
Alvaro Elorza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
PDGF receptor beta is a potent regulator of mesenchymal stromal cell function
Ayano Tokunaga et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies
A. Stolzing et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2008)
Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells
Erxi Wu et al.
PLOS ONE (2008)
Fibroblast growth factor-2 and-4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways
Seung-Cheol Choi et al.
STEM CELLS AND DEVELOPMENT (2008)
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
Hongbing Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells
Laure-Emmanuelle Zaragosi et al.
STEM CELLS (2006)
Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells
Kenichi Tamama et al.
STEM CELLS (2006)
Role of c-jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells
YJ Kang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner
K Krysan et al.
CANCER RESEARCH (2005)
Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation
I Kratchmarova et al.
SCIENCE (2005)
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells
LA Solchaga et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Oncogenic derivatives of platelet-derived growth factor receptors
AV Jones et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells
D Noel et al.
STEM CELLS (2004)
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2
G Bianchi et al.
EXPERIMENTAL CELL RESEARCH (2003)
Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice
M Bonyadi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF
S Tsutsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
